Disease management
The company's SimpleSense wearable will ingest glucose data from the Dexcom G7 continuous glucose monitor system.
Developers at the Chinese University of Hong Kong claim it "communicates like a real doctor."
Also, two Korean digital dentistry solutions providers are integrating AI into their dental diagnostic software.
The company has secured 510(k) clearance for its Apple Watch-powered seizure monitoring platform, expanding the role of wearables in epilepsy care.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.
It is also expected to offer a new digital weight loss program.
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
Also, Heuron started expanding to Japan following an exclusive deal to supply its stroke imaging AI.